Urawa, Japan

Mikio Uchiyama

This inventor holds 2 USPTO granted patents. Top assignee: Eisai Company, Limited. Active years: 1983-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikio Uchiyama. Retrieved from https://idiyas.com/inventor/mikio-uchiyama-fulvo96j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1983-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mikio Uchiyama: Innovator in Biochemistry

Introduction

Mikio Uchiyama is a notable inventor based in Urawa, Japan. He has made significant contributions to the field of biochemistry, particularly in the purification of secretin and the development of heptacosapeptides. With a total of 2 patents, Uchiyama's work has implications for both research and therapeutic applications.

Latest Patents

Uchiyama's latest patents include a process for purifying secretin. This innovative method involves subjecting crude secretin to reversed-phase high-performance liquid chromatography, utilizing a solvent mixture of an acid or its salt and an organic solvent as an eluant. Additionally, he has developed a heptacosapeptide characterized by a specific structural formula, showcasing his expertise in peptide chemistry.

Career Highlights

Mikio Uchiyama is associated with Eisai Company, Limited, where he has been able to apply his research in a corporate setting. His work has contributed to advancements in pharmaceutical sciences, particularly in the development of therapeutic agents.

Collaborations

Uchiyama has collaborated with esteemed colleagues such as Takashi Sato and Yoshihiko Hisatake. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Mikio Uchiyama's contributions to biochemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence research and development in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…